The hTERTα splice variant is a dominant negative inhibitor of telomerase activity

被引:182
作者
Colgin, LM
Wilkinson, C
Englezou, A
Kilian, A
Robinson, MO
Reddel, RR
机构
[1] Childrens Med Res Inst, Westmead, NSW 2145, Australia
[2] CAMBIA, Canberra, ACT 2601, Australia
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源
NEOPLASIA | 2000年 / 2卷 / 05期
关键词
telomerase; telomeres; hTERT; splicing; dominant negative;
D O I
10.1038/sj.neo.7900112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The telomerase catalytic subunit (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of human chromosomes. Maintenance of telomeres by telomerase or another mechanism is required for cell immortalization, and loss of telomeric DNA has been proposed as a trigger for cellular senescence. Available evidence suggests that regulation of telomerase activity primarily depends on transcriptional control of hTERT. However, several human tissues as well as some normal cell strains have been shown to express low levels of hTERT mRNA even though they lack telomerase activity. We have previously identified six splice variants of hTERT, including a "deletion" variant (hTERT alpha) that is missing conserved residues from the catalytic core of the protein. Several of the deletion variants have been detected in normal and developing human tissues. We now show that hTERT alpha inhibits endogenous telomerase activity, which results in telomere shortening and chromosome end-to-end fusions. Telomerase inhibition induced a senescence-like state in HT1080 cells and apoptosis in a jejunal fibroblast cell line. These results suggest a possible role for hTERT splice variants in the regulation of telomerase activity.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 50 条
  • [1] Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA
    Petrenko, A. A.
    Korolenkova, L. I.
    Skvortsov, D. A.
    Federova, M. D.
    Skoblov, M. U.
    Baranova, A. V.
    Zvereva, M. E.
    Rubtsova, M. P.
    Kisseljov, F. L.
    BIOCHIMIE, 2010, 92 (12) : 1827 - 1831
  • [2] Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres
    Guilleret, I
    Benhattar, J
    EXPERIMENTAL CELL RESEARCH, 2003, 289 (02) : 326 - 334
  • [3] Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growth
    Rahman, Ruman
    Mo, Ling
    Cui, Wei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (03) : 796 - 802
  • [4] Telomerase redefined: Integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity
    Cairney, C. J.
    Keith, W. N.
    BIOCHIMIE, 2008, 90 (01) : 13 - 23
  • [5] Telomerase activity and hTERT mRNA expression in body fluids
    Yamamoto, Y
    Hirakawa, E
    DIAGNOSTIC CYTOPATHOLOGY, 2005, 32 (03) : 167 - 170
  • [6] TELOMERASE ACTIVITY AND hTERT mRNA EXPRESSION IN ACUTE LEUKEMIA
    何冬梅
    张洹
    Chinese Journal of Cancer Research, 2004, (04) : 58 - 60
  • [7] Mechanism of dominant-negative telomerase function
    Nguyen, Binh N.
    Elmore, Lynne W.
    Holt, Shawn E.
    CELL CYCLE, 2009, 8 (19) : 3227 - 3233
  • [8] Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity
    Guilleret, I
    Yan, P
    Grange, F
    Braunschweig, R
    Bosman, FT
    Benhattar, J
    INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (04) : 335 - 341
  • [9] Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma
    Barclay, JY
    Morris, A
    Nwokolo, CU
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (02) : 221 - 227
  • [10] Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant
    Delhommeau, FO
    Thierry, A
    Feneux, D
    Lauret, E
    Leclercq, E
    Courtier, MH
    Sainteny, F
    Vainchenker, W
    Bennaceur-Griscelli, A
    ONCOGENE, 2002, 21 (54) : 8262 - 8271